PubMed:10390531
Annnotations
PMID_GLOBAL
{"project":"PMID_GLOBAL","denotations":[{"id":"T1","span":{"begin":11,"end":15},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":11,"end":13},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":20,"end":24},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":20,"end":22},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":25,"end":27},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":176,"end":197},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":199,"end":201},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":277,"end":288},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":311,"end":322},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":329,"end":331},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":379,"end":396},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T13","span":{"begin":398,"end":400},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15","span":{"begin":529,"end":531},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T16","span":{"begin":555,"end":578},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T17","span":{"begin":623,"end":625},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T19","span":{"begin":646,"end":655},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T20","span":{"begin":719,"end":723},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T21","span":{"begin":719,"end":721},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T22","span":{"begin":759,"end":770},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T23","span":{"begin":793,"end":797},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T24","span":{"begin":793,"end":795},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T25","span":{"begin":798,"end":800},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T27","span":{"begin":814,"end":820},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T28","span":{"begin":933,"end":937},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T29","span":{"begin":933,"end":935},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T30","span":{"begin":942,"end":946},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T31","span":{"begin":942,"end":944},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T32","span":{"begin":947,"end":949},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T34","span":{"begin":1029,"end":1032},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T35","span":{"begin":1279,"end":1283},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T36","span":{"begin":1279,"end":1281},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T37","span":{"begin":1288,"end":1292},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T38","span":{"begin":1288,"end":1290},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T39","span":{"begin":1293,"end":1295},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T41","span":{"begin":1408,"end":1411},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T42","span":{"begin":1474,"end":1478},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T43","span":{"begin":1474,"end":1476},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T44","span":{"begin":1577,"end":1581},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T45","span":{"begin":1577,"end":1579},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T46","span":{"begin":1582,"end":1584},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T48","span":{"begin":1804,"end":1808},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T49","span":{"begin":1804,"end":1806},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T50","span":{"begin":1813,"end":1817},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T51","span":{"begin":1813,"end":1815},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T52","span":{"begin":1818,"end":1820},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T54","span":{"begin":1859,"end":1870},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T55","span":{"begin":1874,"end":1878},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T56","span":{"begin":1874,"end":1876},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T57","span":{"begin":1879,"end":1881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T59","span":{"begin":1910,"end":1921},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T60","span":{"begin":1925,"end":1929},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T61","span":{"begin":1925,"end":1927},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T62","span":{"begin":1930,"end":1932},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T64","span":{"begin":1964,"end":1970},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T65","span":{"begin":2026,"end":2032},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0010212"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0019600"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0010212"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0019600"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"0008021"},{"id":"A6","pred":"mondo_id","subj":"T5","obj":"0016006"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"0019600"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"0019600"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0000605"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"0002898"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"0019600"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"0016006"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"0008021"},{"id":"A14","pred":"mondo_id","subj":"T13","obj":"0016006"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"0019600"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"0008840"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"0008021"},{"id":"A18","pred":"mondo_id","subj":"T17","obj":"0016006"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"0000605"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"0010212"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"0019600"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"0000605"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"0010212"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"0019600"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"0008021"},{"id":"A26","pred":"mondo_id","subj":"T25","obj":"0016006"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"0008568"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"0010212"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"0019600"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"0010212"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"0019600"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"0008021"},{"id":"A33","pred":"mondo_id","subj":"T32","obj":"0016006"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"0007064"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"0010212"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"0019600"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"0010212"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"0019600"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"0008021"},{"id":"A40","pred":"mondo_id","subj":"T39","obj":"0016006"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"0007064"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"0010212"},{"id":"A43","pred":"mondo_id","subj":"T43","obj":"0019600"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"0010212"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"0019600"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"0008021"},{"id":"A47","pred":"mondo_id","subj":"T46","obj":"0016006"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"0010212"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"0019600"},{"id":"A50","pred":"mondo_id","subj":"T50","obj":"0010212"},{"id":"A51","pred":"mondo_id","subj":"T51","obj":"0019600"},{"id":"A52","pred":"mondo_id","subj":"T52","obj":"0008021"},{"id":"A53","pred":"mondo_id","subj":"T52","obj":"0016006"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"0000605"},{"id":"A55","pred":"mondo_id","subj":"T55","obj":"0010212"},{"id":"A56","pred":"mondo_id","subj":"T56","obj":"0019600"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"0008021"},{"id":"A58","pred":"mondo_id","subj":"T57","obj":"0016006"},{"id":"A59","pred":"mondo_id","subj":"T59","obj":"0000605"},{"id":"A60","pred":"mondo_id","subj":"T60","obj":"0010212"},{"id":"A61","pred":"mondo_id","subj":"T61","obj":"0019600"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"0008021"},{"id":"A63","pred":"mondo_id","subj":"T62","obj":"0016006"},{"id":"A64","pred":"mondo_id","subj":"T64","obj":"0008568"},{"id":"A65","pred":"mondo_id","subj":"T65","obj":"0008568"}],"text":"Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.\nXeroderma pigmentosum (XP) is a rare hereditary human disorder clinically associated with severe sun sensitivity and predisposition to skin cancer. Some XP patients also show clinical characteristics of Cockayne syndrome (CS), a disorder associated with defective preferential repair of DNA lesions in transcriptionally active genes. Cells from the two XP-patients who belong to complementation group D and exhibit additional clinical symptoms of CS are strikingly more sensitive to the cytotoxic effects of UV-light than cells from classical XP-D patients. To explain the severe UV-sensitivity it was suggested that XP-D-CS cells have a defect in preferential repair of UV-induced 6-4 photoproducts (6-4PP) in active genes. We investigated the capacity of XP-D and XP-D-CS cells to repair UV-induced DNA lesions in the active adenosine deaminase gene (ADA) and in the inactive 754 gene by determining (i) the removal of specific lesions, i.e. cyclobutane pyrimidine dimers (CPD) and 6-4PP, or (ii) the formation of BrdUrd-labeled repair patches. No differences in repair capacity were observed between XP-D and XP-D-CS cells. In both cell types repair of CPD was completely absent whereas 6-4PP were inefficiently removed from the ADA gene and the 754 gene with similar kinetics. However, whereas XP-D cells were able to restore UV-inhibited RNA synthesis after a UV-dose of 2 J/m2, RNA synthesis in XP-D-CS cells remained repressed up to 24 h after irradiation. Our results are inconsistent with the hypothesis that differences in the capacity to perform preferential repair of UV-induced photolesions in active genes between XP-D and XP-D-CS cells are the cause of the extreme UV-sensitivity of XP-D-CS cells. Rather, the enhanced sensitivity of XP-D-CS cells may be associated with a defect in transcription regulation superimposed on the repair defect."}
DisGeNET5_gene_disease
{"project":"DisGeNET5_gene_disease","denotations":[{"id":"10390531-5#102#121#gene100","span":{"begin":1003,"end":1022},"obj":"gene100"},{"id":"10390531-5#46#48#diseaseC0009207","span":{"begin":947,"end":949},"obj":"diseaseC0009207"}],"relations":[{"id":"102#121#gene10046#48#diseaseC0009207","pred":"associated_with","subj":"10390531-5#102#121#gene100","obj":"10390531-5#46#48#diseaseC0009207"}],"text":"Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.\nXeroderma pigmentosum (XP) is a rare hereditary human disorder clinically associated with severe sun sensitivity and predisposition to skin cancer. Some XP patients also show clinical characteristics of Cockayne syndrome (CS), a disorder associated with defective preferential repair of DNA lesions in transcriptionally active genes. Cells from the two XP-patients who belong to complementation group D and exhibit additional clinical symptoms of CS are strikingly more sensitive to the cytotoxic effects of UV-light than cells from classical XP-D patients. To explain the severe UV-sensitivity it was suggested that XP-D-CS cells have a defect in preferential repair of UV-induced 6-4 photoproducts (6-4PP) in active genes. We investigated the capacity of XP-D and XP-D-CS cells to repair UV-induced DNA lesions in the active adenosine deaminase gene (ADA) and in the inactive 754 gene by determining (i) the removal of specific lesions, i.e. cyclobutane pyrimidine dimers (CPD) and 6-4PP, or (ii) the formation of BrdUrd-labeled repair patches. No differences in repair capacity were observed between XP-D and XP-D-CS cells. In both cell types repair of CPD was completely absent whereas 6-4PP were inefficiently removed from the ADA gene and the 754 gene with similar kinetics. However, whereas XP-D cells were able to restore UV-inhibited RNA synthesis after a UV-dose of 2 J/m2, RNA synthesis in XP-D-CS cells remained repressed up to 24 h after irradiation. Our results are inconsistent with the hypothesis that differences in the capacity to perform preferential repair of UV-induced photolesions in active genes between XP-D and XP-D-CS cells are the cause of the extreme UV-sensitivity of XP-D-CS cells. Rather, the enhanced sensitivity of XP-D-CS cells may be associated with a defect in transcription regulation superimposed on the repair defect."}
DisGeNET
{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":1003,"end":1022},"obj":"gene:100"},{"id":"T1","span":{"begin":933,"end":935},"obj":"disease:C0043346"},{"id":"T2","span":{"begin":1003,"end":1022},"obj":"gene:100"},{"id":"T3","span":{"begin":942,"end":944},"obj":"disease:C0043346"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.\nXeroderma pigmentosum (XP) is a rare hereditary human disorder clinically associated with severe sun sensitivity and predisposition to skin cancer. Some XP patients also show clinical characteristics of Cockayne syndrome (CS), a disorder associated with defective preferential repair of DNA lesions in transcriptionally active genes. Cells from the two XP-patients who belong to complementation group D and exhibit additional clinical symptoms of CS are strikingly more sensitive to the cytotoxic effects of UV-light than cells from classical XP-D patients. To explain the severe UV-sensitivity it was suggested that XP-D-CS cells have a defect in preferential repair of UV-induced 6-4 photoproducts (6-4PP) in active genes. We investigated the capacity of XP-D and XP-D-CS cells to repair UV-induced DNA lesions in the active adenosine deaminase gene (ADA) and in the inactive 754 gene by determining (i) the removal of specific lesions, i.e. cyclobutane pyrimidine dimers (CPD) and 6-4PP, or (ii) the formation of BrdUrd-labeled repair patches. No differences in repair capacity were observed between XP-D and XP-D-CS cells. In both cell types repair of CPD was completely absent whereas 6-4PP were inefficiently removed from the ADA gene and the 754 gene with similar kinetics. However, whereas XP-D cells were able to restore UV-inhibited RNA synthesis after a UV-dose of 2 J/m2, RNA synthesis in XP-D-CS cells remained repressed up to 24 h after irradiation. Our results are inconsistent with the hypothesis that differences in the capacity to perform preferential repair of UV-induced photolesions in active genes between XP-D and XP-D-CS cells are the cause of the extreme UV-sensitivity of XP-D-CS cells. Rather, the enhanced sensitivity of XP-D-CS cells may be associated with a defect in transcription regulation superimposed on the repair defect."}
PubmedHPO
{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":273,"end":288},"obj":"HP_0000992"},{"id":"T2","span":{"begin":311,"end":322},"obj":"HP_0008069"},{"id":"T3","span":{"begin":316,"end":322},"obj":"HP_0002664"}],"text":"Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.\nXeroderma pigmentosum (XP) is a rare hereditary human disorder clinically associated with severe sun sensitivity and predisposition to skin cancer. Some XP patients also show clinical characteristics of Cockayne syndrome (CS), a disorder associated with defective preferential repair of DNA lesions in transcriptionally active genes. Cells from the two XP-patients who belong to complementation group D and exhibit additional clinical symptoms of CS are strikingly more sensitive to the cytotoxic effects of UV-light than cells from classical XP-D patients. To explain the severe UV-sensitivity it was suggested that XP-D-CS cells have a defect in preferential repair of UV-induced 6-4 photoproducts (6-4PP) in active genes. We investigated the capacity of XP-D and XP-D-CS cells to repair UV-induced DNA lesions in the active adenosine deaminase gene (ADA) and in the inactive 754 gene by determining (i) the removal of specific lesions, i.e. cyclobutane pyrimidine dimers (CPD) and 6-4PP, or (ii) the formation of BrdUrd-labeled repair patches. No differences in repair capacity were observed between XP-D and XP-D-CS cells. In both cell types repair of CPD was completely absent whereas 6-4PP were inefficiently removed from the ADA gene and the 754 gene with similar kinetics. However, whereas XP-D cells were able to restore UV-inhibited RNA synthesis after a UV-dose of 2 J/m2, RNA synthesis in XP-D-CS cells remained repressed up to 24 h after irradiation. Our results are inconsistent with the hypothesis that differences in the capacity to perform preferential repair of UV-induced photolesions in active genes between XP-D and XP-D-CS cells are the cause of the extreme UV-sensitivity of XP-D-CS cells. Rather, the enhanced sensitivity of XP-D-CS cells may be associated with a defect in transcription regulation superimposed on the repair defect."}